These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1992149)

  • 1. Relationship between tissue selectivity and lipophilicity for inhibitors of HMG-CoA reductase.
    Roth BD; Bocan TM; Blankley CJ; Chucholowski AW; Creger PL; Creswell MW; Ferguson E; Newton RS; O'Brien P; Picard JA
    J Med Chem; 1991 Jan; 34(1):463-6. PubMed ID: 1992149
    [No Abstract]   [Full Text] [Related]  

  • 2. A potent, tissue-selective, synthetic inhibitor of HMG-CoA reductase.
    Balasubramanian N; Brown PJ; Catt JD; Han WT; Parker RA; Sit SY; Wright JJ
    J Med Chem; 1989 Sep; 32(9):2038-41. PubMed ID: 2769677
    [No Abstract]   [Full Text] [Related]  

  • 3. 3-Alkyl-3-hydroxyglutaric acids: a new class of hypocholesterolemic HMG CoA reductase inhibitors. 1.
    Baran JS; Laos I; Langford DD; Miller JE; Jett C; Taite B; Rohrbacher E
    J Med Chem; 1985 May; 28(5):597-601. PubMed ID: 3989819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Farnesol is not the nonsterol regulator mediating degradation of HMG-CoA reductase in rat liver.
    Keller RK; Zhao Z; Chambers C; Ness GC
    Arch Biochem Biophys; 1996 Apr; 328(2):324-30. PubMed ID: 8645011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorus-containing inhibitors of HMG-CoA reductase. 1. 4-[(2-arylethyl)hydroxyphosphinyl]-3-hydroxy-butanoic acids: a new class of cell-selective inhibitors of cholesterol biosynthesis.
    Karanewsky DS; Badia MC; Ciosek CP; Robl JA; Sofia MJ; Simpkins LM; DeLange B; Harrity TW; Biller SA; Gordon EM
    J Med Chem; 1990 Nov; 33(11):2952-6. PubMed ID: 2231594
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of pravastatin on hepatic 3-hydroxy-3-methylglutaryl CoA reductase obtained from poloxamer 407-induced hyperlipidemic rats.
    Johnston TP; Palmer WK
    Pharmacotherapy; 1997; 17(2):342-7. PubMed ID: 9085326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mevinolin: a highly specific inhibitor of microsomal 3-hydroxy-3-methylglutaryl-coenzyme A reductase of radish plants.
    Bach TJ; Lichtenthaler HK
    Z Naturforsch C Biosci; 1982; 37(1-2):46-50. PubMed ID: 6917646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of inhibition by mevinolin (MK 803) of microsome-bound radish and of partially purified yeast HMG-CoA reductase (EC.1.1.1.34).
    Bach TJ; Lichtenthaler HK
    Z Naturforsch C Biosci; 1983; 38(3-4):212-9. PubMed ID: 6553442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypocholesterolemic agents VII: Inhibition of beta-hydroxy-beta-methylglutaryl-CoA reductase by monoesters of substituted glutaric acids.
    Boots MR; Yeh YM; Boots SG
    J Pharm Sci; 1980 May; 69(5):506-9. PubMed ID: 7381731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, biological profile, and quantitative structure-activity relationship of a series of novel 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
    Sit SY; Parker RA; Motoc I; Han W; Balasubramanian N; Catt JD; Brown PJ; Harte WE; Thompson MD; Wright JJ
    J Med Chem; 1990 Nov; 33(11):2982-99. PubMed ID: 2231596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological activity of new HMG-CoA reductase inhibitors. 3. Lactones of 6-phenoxy-3,5-dihydroxyhexanoic acids.
    Jendralla H; Granzer E; von Kerekjarto B; Krause R; Schacht U; Baader E; Bartmann W; Beck G; Bergmann A; Kesseler K
    J Med Chem; 1991 Oct; 34(10):2962-83. PubMed ID: 1656041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monacolin K, a new hypocholesterolemic agent that specifically inhibits 3-hydroxy-3-methylglutaryl coenzyme A reductase.
    Endo A
    J Antibiot (Tokyo); 1980 Mar; 33(3):334-6. PubMed ID: 7380744
    [No Abstract]   [Full Text] [Related]  

  • 13. Sex difference in inhibition of in vitro mexazolam metabolism by various 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors in rat liver microsomes.
    Ishigami M; Takasaki W; Ikeda T; Komai T; Ito K; Sugiyama Y
    Drug Metab Dispos; 2002 Aug; 30(8):904-10. PubMed ID: 12124308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regioselectivity and stereoselectivity in the metabolism of HMG-CoA reductase inhibitors.
    Vyas KP; Kari PH; Pitzenberger SM
    Biochem Biophys Res Commun; 1990 Feb; 166(3):1155-62. PubMed ID: 2306236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol.
    Reihnér E; Rudling M; Ståhlberg D; Berglund L; Ewerth S; Björkhem I; Einarsson K; Angelin B
    N Engl J Med; 1990 Jul; 323(4):224-8. PubMed ID: 2114543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of rat liver hydroxymethylglutaryl coenzyme A reductase by a new class of noncompetitive inhibitors. Effects of dichloroacetate and related carboxylic acids on enzyme activity.
    Stacpoole PW; Harwood HJ; Varnado CE
    J Clin Invest; 1983 Nov; 72(5):1575-85. PubMed ID: 6630519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic and nonhepatic sterol synthesis and tissue distribution following administration of a liver selective HMG-CoA reductase inhibitor, CI-981: comparison with selected HMG-CoA reductase inhibitors.
    Bocan TM; Ferguson E; McNally W; Uhlendorf PD; Bak Mueller S; Dehart P; Sliskovic DR; Roth BD; Krause BR; Newton RS
    Biochim Biophys Acta; 1992 Jan; 1123(2):133-44. PubMed ID: 1739744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the effects of 3-hydroxy-3-methylglutaryl-coenzyme a (HMG-CoA) reductase inhibitors on the CYP3A4-dependent oxidation of mexazolam in vitro.
    Ishigami M; Honda T; Takasaki W; Ikeda T; Komai T; Ito K; Sugiyama Y
    Drug Metab Dispos; 2001 Mar; 29(3):282-8. PubMed ID: 11181496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by ML-236A and ML-236B fungal metabolites, having hypocholesterolemic activity.
    Endo A; Kuroda M; Tanzawa K
    FEBS Lett; 1976 Dec; 72(2):323-6. PubMed ID: 16386050
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of 15-oxa-32-vinyl-lanost-8-ene-3 beta,32 diol on the expression of 3-hydroxy-3-methylglutaryl coenzyme A reductase and low density lipoprotein receptor in rat liver.
    Ness GC; Lopez D; Chambers CM; Zhao Z; Beach DL; Ko SS; Trzaskos JM
    Arch Biochem Biophys; 1998 Sep; 357(2):259-64. PubMed ID: 9735166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.